Omer Faruk Karatas
Overview
Explore the profile of Omer Faruk Karatas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
806
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Capik O, Karatas O
Cell Oncol (Dordr)
. 2025 Feb;
PMID: 39928285
Hypoxia is a critical microenvironmental condition that plays a major role in driving tumorigenesis and cancer progression. Increasing evidence has revealed novel functions of hypoxia in intercellular communication. The hypoxia...
2.
An M, Akyuz M, Capik O, Yalcin C, Bertram R, Karatas E, et al.
Math Biosci
. 2024 May;
374:109224.
PMID: 38821258
Gain of function mutations in the pore forming Kir6 subunits of the ATP sensitive K channels (K(ATP) channels) of pancreatic β-cells are the major cause of neonatal diabetes in humans....
3.
Caglar H, Aytatli A, Barlak N, Karatas E, Tatar A, Sahin A, et al.
Head Neck
. 2024 May;
46(9):2178-2196.
PMID: 38752376
Background: This study aimed to identify a candidate gene associated with paclitaxel (PTX) resistance and to evaluate functionally its biological role in the PTX-resistant head and neck squamous cell carcinoma...
4.
Sanli F, Tatar A, Gundogdu B, Karatas O
Eur J Pharmacol
. 2024 Apr;
973:176592.
PMID: 38642666
Head and neck cancer (HNC) is the sixth most common malignancy worldwide. Although current modalities offer a wide variety of therapy choices, head and neck carcinoma has poor prognosis due...
5.
Urvasizoglu G, Kilic A, Capik O, Gundogdu M, Karatas O
Odontology
. 2023 Dec;
112(3):864-871.
PMID: 38087011
Peri-implantitis develops in 43.3% of implant patients, which affects tissues around the implant that may ultimately cause implant loss if not treated properly. Due to difficulties in detecting peri-implantitis in...
6.
Manap S, Medetalibeyoglu H, Kilic A, Karatas O, Tuzun B, Alkan M, et al.
J Biomol Struct Dyn
. 2023 Oct;
42(21):11916-11930.
PMID: 37840297
A series of biologically active novel Mannich bases containing with a 1-1,2,4-triazole-5-one ring were developed to evaluate the cytotoxic activity. For this purpose, the synthesized Schiff Bases () were reacted...
7.
Capik O, Gundogdu B, Tatar A, Sahin A, Chen F, Creighton C, et al.
J Cell Biochem
. 2023 Sep;
124(10):1628-1645.
PMID: 37683055
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignant cancer type worldwide. Although the therapeutic modalities currently used for patients with HNSCC improved in recent decades,...
8.
Yuriy K, Kusdemir G, Volodymyr P, Tuzun B, Taslimi P, Karatas O, et al.
J Biomol Struct Dyn
. 2023 Sep;
42(3):1220-1236.
PMID: 37671856
In this study, we researched the reactions of 5-(5-bromofuran-2-yl)-4-methyl-1,2,4-triazole-3-thiol and 5-thiophene-(3-ylmethyl)-4R-1,2,4-triazole-3-thiols with some halogen-containing compounds, a number of new compounds were synthesized ( and ). These compounds showed excellent to...
9.
Barlak N, Kusdemir G, Gumus R, Gundogdu B, Sahin M, Tatar A, et al.
Cell Biol Int
. 2023 Aug;
47(12):1950-1963.
PMID: 37641160
Head and neck squamous cell carcinoma (HNSCC) is one of the most aggressive neoplasms, which requires more effective prevention and treatment modalities. Previous studies found that protein O-fucosyltransferase 1 (POFUT1)...
10.
Ertugrul B, Aytatli A, Karatas O, Saracoglu N
RSC Med Chem
. 2023 Jul;
14(7):1362-1376.
PMID: 37484572
Modulation of existing drugs is an attractive strategy to achieve improved activity in cancer therapy by lowering their effective dose. Preparation of relatives has been suggested and explored to improve...